March 2019 FDA Recall Drug by Pfizer Inc.
D-1073-2019 - Presence of Particulate Matter; glass particulates

This Class I drug recall was voluntarily initiated by Pfizer Inc. on March 15, 2019 for the product Drug. The FDA reported the reason for recall as presence of particulate matter; glass particulates. The product was distributed in United States and Puerto Rico and the recall is currently terminated.

Recall Number: D-1073-2019

Reason for Recall
Presence of Particulate Matter; glass particulates
Initiated
03-15-2019
Reported
04-10-2019
Quantity
283,400 vials

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
United States and Puerto Rico
8.4% Sodium Bicarbonate Injection, USP 50 mEq (1 mEq/mL) 4.2 grams (84 mg/mL) 50 mL Single-dose fliptop vial, 25 vials per carton, Rx only Hospira, Inc. Lake Forest, IL 60045 USA ---- NDC 0409-6625-02

Batch or Lot Expiration Information

Lot# Lots: 79-238-EV Exp. 1 July 2019; 79-240-EV Exp. 1 July 2019; 80-088-EV Exp. 1 August 2019